Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-16T15:16:28.296Z Has data issue: false hasContentIssue false
  • English
  • Français

Something Borrowed, Something Blue: Why is Bipolar Disorder an Orphan?

Published online by Cambridge University Press:  07 November 2014

Andrew A. Nierenberg
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
CNS Spectrums , Volume 15 , Issue 1 , January 2010 , pp. 15 - 16
Copyright
Copyright © Cambridge University Press 2010

References

REFERENCES

1.Grant, BF, Stinson, FS, Hasin, DS, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005; 66: 1205–1215.CrossRefGoogle ScholarPubMed
2.Merikangas, KR, Akiskal, HS, Angst, J, et al. Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2007; 64: 543–552.CrossRefGoogle ScholarPubMed
3.Perlis, RH, Miyahara, S, Marangell, LB, et al. Long-term implications of early onset in bipolar disorder: Data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry. 2004; 55: 875–881.CrossRefGoogle ScholarPubMed
4.Post, RM, Luckenbaugh, DA, Leverich, GS, et al. Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry. 2008; 192: 150–151.CrossRefGoogle ScholarPubMed
5.Judd, LL, Akiskal, HS, Schettler, PJ, et al. Psychosocial Disability in the Course of Bipolar I and II Disorders: A Prospective, Comparative, Longitudinal Study. Arch Gen Psychiatry. 2005; 62: 1322–1330.CrossRefGoogle ScholarPubMed
6.Judd, LL, Schettler, PJ, Solomon, DA, et al. Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. J Affect Disord. 2008; 108: 49–58.CrossRefGoogle ScholarPubMed
7.Murray, CJL, Lopez, AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349: 1436–1442.CrossRefGoogle ScholarPubMed
8.Angst, J, Angst, F, Gerber-Werder, R, Gamma, A. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res. 2005; 9: 279.CrossRefGoogle ScholarPubMed
9.Bostwick, JM, Pankratz, VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry. 2000; 157: 1925–1932.CrossRefGoogle Scholar
10.Nierenberg, AA, Gray, SM, Grandin, LD. Mood disorders and suicide. J Clin Psychiatry. 2001; 62: 27–30.Google ScholarPubMed
11.Begley, CE, Annegers, JF, Swann, AC, et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics. 2001; 19: 483–495.CrossRefGoogle ScholarPubMed
12.Insel, TR. Assessing the Economic Costs of Serious Mental Illness. Am J Psychiatry. 2008; 165: 663–665.CrossRefGoogle ScholarPubMed
13.Bowden, CL. Anticonvulsants in bipolar disorders: current research and practice and future directions. Bipolar Disord. 2009; 11: 20–33.CrossRefGoogle ScholarPubMed
14.Bowden, CL, Brugger, AM, Swann, AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA. 1994; 271: 918–24.CrossRefGoogle ScholarPubMed
15.Bowden, CL, Calabrese, JR, McElroy, SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 2000; 57: 481–489.CrossRefGoogle ScholarPubMed
16.Bowden, CL, Calabrese, JR, Sachs, G, et al. A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder. Arch Gen Psychiatry. 2003; 60: 392–400.CrossRefGoogle ScholarPubMed
17.Calabrese, JR, Bowden, CL, Sachs, G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003; 64: 1013–1024.CrossRefGoogle ScholarPubMed
18.Calabrese, JR, Bowden, CL, Sachs, GS, Ascher, JA, Monaghan, E, Rudd, GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry. 1999; 60: 79–88.CrossRefGoogle ScholarPubMed
19.Brown, EB, McElroy, SL, Keck, PE, et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry. 2006; 67: 1025–1033.CrossRefGoogle ScholarPubMed
20.Tohen, M, Calabrese, J, Vieta, E, et al. Effect of comorbid anxiety on treatment response in bipolar depression. J Affect Disord. 2007; 104: 137–146.CrossRefGoogle ScholarPubMed
21.Tohen, M, Vieta, E, Calabrese, J, et al. Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression. Arch Gen Psychiatry. 2003; 60: 1079–1088.CrossRefGoogle ScholarPubMed
22.Scherk, H, Pajonk, FG, Leucht, S. Second-Generation Antipsychotic Agents in the Treatment of Acute Mania: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Arch Gen Psychiatry. 2007; 64: 442–455.CrossRefGoogle Scholar
23.Sachs, GS, Nierenberg, AA, Calabrese, JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007; 356: 1711–1722.CrossRefGoogle ScholarPubMed
24.Frye, MA, Grunze, H, Suppes, T, et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry. 2007; 164: 1242–1249.CrossRefGoogle ScholarPubMed
25.Zarate, CA Jr., Quiroz, JA, Singh, JB, et al. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry. 2005; 57: 430–432.CrossRefGoogle ScholarPubMed
26.Grof, P, Muller-Oerlinghausen, B. A critical appraisal of lithium's efficacy and effectiveness: the last 60 years. Bipolar Disord. 2009; 11(Suppl 2): 10–19.CrossRefGoogle ScholarPubMed
27.Cade, JF. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949; 2: 349–352.CrossRefGoogle ScholarPubMed
28.Mitchell, PB. On the 50th anniversary of John Cade's discovery of the anti-manic effect of lithium. Aust N Z J Psychiatry. 1999; 33: 623–628.Google ScholarPubMed
29.Schou, M, Juel-Nelson, N, Stromgren, E, Voldby, H.The treatment of manic psychosisby the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954; 17: 250–260.CrossRefGoogle ScholarPubMed
30.Coates, DA, Trautner, EM, Gershon, S.Treatment of lithium poisoning. Aust Ann Med. 1957; 1: 11–15.CrossRefGoogle Scholar
31.Lerer, B, Moore, N, Meyendorff, E, Cho, SR, Gershon, S.Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry. 1987; 48: 89–93.Google Scholar
32.Suppes, T, Dennehy, EB, Hirschfeld, RMA, et al. The Texas Implementation of Medication Algorithms: Update to the Algorithms for Treatment of Bipolar I Disorder. J Clin Psychiatry. 2005; 66: 870–886.CrossRefGoogle Scholar
33.Perlis, RH, Smoller, JW, Ferreira, MA, et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry. 2009; 166: 718–25.CrossRefGoogle ScholarPubMed
34.Chuang, D-M, Manji, HK. In Search of the Holy Grail for the Treatment of Neurodegenerative Disorders: Has a Simple Cation Been Overlooked? Biol Psychiatry. 2007; 62: 4–6.CrossRefGoogle Scholar
35.Manji, H, Moore, G, Chen, G.Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry. 2000; 48: 740–754.CrossRefGoogle ScholarPubMed
36.Rodrigo, M-V, Husseini, KM, Carlos, AZ Jr., The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009; 11: 92–109.Google Scholar
37.Gijsman, HJ, Geddes, JR, Rendell, JM, Nolen, WA, Goodwin, GM. Antidepressants for bipolar depression: A systematic review of randomized, controlled trials. Am J Psychiatry. 2004; 161: 1537–1547.CrossRefGoogle ScholarPubMed
38.Thase, ME. Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (The BOLDER II study). J Clin Psychopharmacol. 2006; 26: 600–609.CrossRefGoogle Scholar